Presentations: Phase I trial in critical limb ischaemia
CFO Michael Hunt Presents at Shares Magazine Investor Evening – 27th October 2016
CEO Presents at the 6th Annual Cell & Gene Partnering Forum on the Mesa 2016
CEO Presents at Cell & Gene Therapy Investor Day March 2016
Section: News
News
Filter by:
Corporate
Product
Induced pluripotent stem cell (iPSC) Platform
CTX cells for Stroke Disability
CTX cells for Critical Limb Ischaemia
hRPCs for Retinitis Pigmentosa
CTX-derived Exosomes
Trial
Phase III clinical trial in stroke disability (PISCES-III)
Phase I clinical trial in stroke disability (PISCES)
Phase II clinical trial in stroke disability (PISCES-II)
Observational study in stroke
Phase I trial in critical limb ischaemia
Phase I/II clinical trial in retinitis pigmentosa